Conducting phase 1 cancer clinical trials during the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)-related disease pandemic

被引：12

作者：

Tarantino, Paolo ^{[1
,2
]}

Trapani, Dario ^{[1
]}

Curigliano, Giuseppe ^{[1
,2
]}

机构：

[1] IRCCS, European Inst Oncol, Milan, Italy

[2] Univ Milan, Milan, Italy

来源：

EUROPEAN JOURNAL OF CANCER | 2020年 / 132卷

关键词：

D O I：

10.1016/j.ejca.2020.03.023

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：8 / 10

页数：3

共 6 条

[1] Phase I trials as valid therapeutic options for patients with cancer [J].

Adashek, Jacob J. ;

LoRusso, Patricia M. ;

Hong, David S. ;

Kurzrock, Razelle .

NATURE REVIEWS CLINICAL ONCOLOGY, 2019, 16 (12) :773-778

[2] COVID-19 control in China during mass population movements at New Year [J].

Chen, Simiao ;

Yang, Juntao ;

Yang, Weizhong ;

Wang, Chen ;

Barnighausen, Till .

LANCET, 2020, 395 (10226) :764-766

[3]

Hollander JE, 2020, NEW ENGL J MED, DOI [10.1056/NEJMp2003539.NEJMp.2003539., DOI 10.1056/NEJMP2003539.NEJMP.2003539]

[4] Case-Fatality Rate and Characteristics of Patients Dying in Relation to COVID-19 in Italy [J].

Onder, Graziano ;

Rezza, Giovanni ;

Brusaferro, Silvio .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (18) :1775-1776

[5] COVID-19 and Italy: what next? [J].

Remuzzi, Andrea ;

Remuzzi, Giuseppe .

LANCET, 2020, 395 (10231) :1225-1228

[6]

Wang HP, 2020, LANCET ONCOL, V21, pE181, DOI 10.1016/S1470-2045(20)30149-2

← 1 →